CN101205215B - 一种西多福韦关键中间体的制备方法 - Google Patents
一种西多福韦关键中间体的制备方法 Download PDFInfo
- Publication number
- CN101205215B CN101205215B CN 200610165392 CN200610165392A CN101205215B CN 101205215 B CN101205215 B CN 101205215B CN 200610165392 CN200610165392 CN 200610165392 CN 200610165392 A CN200610165392 A CN 200610165392A CN 101205215 B CN101205215 B CN 101205215B
- Authority
- CN
- China
- Prior art keywords
- compound
- formula
- cidofovir
- solvent
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 11
- VWFCHDSQECPREK-LURJTMIESA-N Cidofovir Chemical compound NC=1C=CN(C[C@@H](CO)OCP(O)(O)=O)C(=O)N=1 VWFCHDSQECPREK-LURJTMIESA-N 0.000 title abstract description 12
- 229960000724 cidofovir Drugs 0.000 title abstract description 11
- 150000001875 compounds Chemical class 0.000 claims abstract description 39
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- 238000006243 chemical reaction Methods 0.000 claims description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 11
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 6
- 238000001953 recrystallisation Methods 0.000 claims description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 5
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 4
- 239000003513 alkali Substances 0.000 claims description 3
- 239000003054 catalyst Substances 0.000 claims description 3
- JCVHIWLGFNCDAR-NFJMKROFSA-N (2R)-2-bromo-3-methyloxirane Chemical compound Br[C@@H]1C(C)O1 JCVHIWLGFNCDAR-NFJMKROFSA-N 0.000 claims description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- LRWZZZWJMFNZIK-UHFFFAOYSA-N 2-chloro-3-methyloxirane Chemical compound CC1OC1Cl LRWZZZWJMFNZIK-UHFFFAOYSA-N 0.000 claims description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical group CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 230000001476 alcoholic effect Effects 0.000 claims description 2
- 238000005576 amination reaction Methods 0.000 claims description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 2
- 239000012046 mixed solvent Substances 0.000 claims description 2
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims description 2
- 239000003443 antiviral agent Substances 0.000 abstract description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 18
- 238000002360 preparation method Methods 0.000 description 17
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 10
- 235000019441 ethanol Nutrition 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 229940104302 cytosine Drugs 0.000 description 5
- -1 isopropylidene glycol derivative Chemical class 0.000 description 5
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- LRWZZZWJMFNZIK-NFJMKROFSA-N (2R)-2-chloro-3-methyloxirane Chemical compound CC1O[C@@H]1Cl LRWZZZWJMFNZIK-NFJMKROFSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- GKIPXFAANLTWBM-UHFFFAOYSA-N epibromohydrin Chemical compound BrCC1CO1 GKIPXFAANLTWBM-UHFFFAOYSA-N 0.000 description 2
- 125000000654 isopropylidene group Chemical group C(C)(C)=* 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 1
- 206010048843 Cytomegalovirus chorioretinitis Diseases 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- 241000701085 Human alphaherpesvirus 3 Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 208000001763 cytomegalovirus retinitis Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 208000003154 papilloma Diseases 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 150000008318 pyrimidones Chemical class 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Landscapes
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200610165392 CN101205215B (zh) | 2006-12-19 | 2006-12-19 | 一种西多福韦关键中间体的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200610165392 CN101205215B (zh) | 2006-12-19 | 2006-12-19 | 一种西多福韦关键中间体的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101205215A CN101205215A (zh) | 2008-06-25 |
CN101205215B true CN101205215B (zh) | 2010-05-26 |
Family
ID=39565712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200610165392 Active CN101205215B (zh) | 2006-12-19 | 2006-12-19 | 一种西多福韦关键中间体的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101205215B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1690067A (zh) * | 2004-04-19 | 2005-11-02 | 横店集团成都分子实验室有限公司 | 抗病毒剂环西多福韦新衍生物 |
CN1690065A (zh) * | 2004-04-19 | 2005-11-02 | 横店集团成都分子实验室有限公司 | 抗病毒剂西多福韦新衍生物及中间体 |
CN1690066A (zh) * | 2004-04-19 | 2005-11-02 | 横店集团成都分子实验室有限公司 | 抗病毒剂西多福韦新衍生物 |
-
2006
- 2006-12-19 CN CN 200610165392 patent/CN101205215B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1690067A (zh) * | 2004-04-19 | 2005-11-02 | 横店集团成都分子实验室有限公司 | 抗病毒剂环西多福韦新衍生物 |
CN1690065A (zh) * | 2004-04-19 | 2005-11-02 | 横店集团成都分子实验室有限公司 | 抗病毒剂西多福韦新衍生物及中间体 |
CN1690066A (zh) * | 2004-04-19 | 2005-11-02 | 横店集团成都分子实验室有限公司 | 抗病毒剂西多福韦新衍生物 |
Non-Patent Citations (4)
Title |
---|
Mikhailov, S. N. et al..Nonglycosidic analogs of nucleotides: 2'(R),3'(S),5'-trihydroxypentyl derivatives of adenine and cytosine.Tetrahedron32.1976,322409-2415. |
Mikhailov,S.N.et al..Nonglycosidic analogs of nucleotides: 2'(R),3'(S),5'-trihydroxypentyl derivatives of adenine and cytosine.Tetrahedron32.1976,322409-2415. * |
易红 等.抗病毒药物西多福韦的合成研究.中国抗生素杂志31 7.2006,31(7),412-413,436. |
易红等.抗病毒药物西多福韦的合成研究.中国抗生素杂志31 7.2006,31(7),412-413,436. * |
Also Published As
Publication number | Publication date |
---|---|
CN101205215A (zh) | 2008-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2011001872A (es) | Moduladores de mif. | |
CN102311437A (zh) | 一种抗血小板凝集药替卡格雷的制备方法 | |
CN113307833A (zh) | N4-羟基胞苷的制备方法 | |
CN113278040A (zh) | 5’-异丁酰基-n4-羟基胞苷的制备方法 | |
CN103819450B (zh) | 一种苯甲酸阿格列汀的新制备方法 | |
CN101205228A (zh) | 磷酸二酯酶5抑制剂他达拉非的合成方法 | |
KR940008421B1 (ko) | 신규의 9-디아자구아닌 | |
EP0150469A1 (en) | Thieno(2,3-d)pyrimidine derivatives and salts thereof | |
WO2000051990A1 (en) | Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereof | |
CN101205215B (zh) | 一种西多福韦关键中间体的制备方法 | |
CN110981816B (zh) | 一种4-氨基-2.6-二甲氧基嘧啶的合成方法 | |
Camarasa et al. | Synthesis and antiviral activity of 3'-C-cyano-3'-deoxynucleosides | |
Kundu et al. | Synthesis and biological activities of [E]-5-(2-acylvinyl) uracils | |
CN112778347B (zh) | 一种硼氮苯并咔唑衍生物的合成方法 | |
JP2780843B2 (ja) | プリニルおよびピリミジニルテトラヒドロフラン類 | |
CN114014749A (zh) | 一类4-羟基联苯类衍生物、制备方法及应用 | |
CN100412083C (zh) | 一组六元碳环核苷类似物及其合成方法和在抗病毒方面的应用 | |
CN1352637A (zh) | Mkc-442的制备方法 | |
CN101066987A (zh) | 溴呋啶的制备方法 | |
CN101555248B (zh) | 一种多取代1,5-萘啶化合物的制备方法 | |
CN101041636B (zh) | 一种合成杂环烯酮缩胺衍生物的方法 | |
CN115232079B (zh) | 一种嘧啶类神经氨酸酶抑制剂及其制备方法与应用 | |
JPH0528709B2 (zh) | ||
WO2018059288A1 (zh) | 一种马西替坦及其中间体化合物的制备方法 | |
EP4119138A1 (en) | Dhodh inhibitors and their use as antiviral agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20161214 Address after: 570314 Nanhai Avenue, Hainan, Haikou, China, No. 279 Patentee after: Aventis Pharma (Hainan) Co., Ltd. Address before: 100097 Beijing city Haidian District Sijiqing Wanquan Zhuang 3 Building Patentee before: Beijing Dezhong Wanquan Medicine Technology Development Co., Ltd. |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Aventis Pharma (Hainan) Co., Ltd. Document name: Notification to Pay the Fees |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 570314 Nanhai Avenue 279, Haikou City, Hainan Province Patentee after: Beijing D-Venturepharm Technology Development Co., Ltd. Address before: 570314 Nanhai Avenue 279, Haikou City, Hainan Province Patentee before: Aventis Pharma (Hainan) Co., Ltd. |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Beijing D-Venturepharm Technology Development Co., Ltd. Document name: Notification of Passing Examination on Formalities |